-
16 May 2022
Ukrainian LGBTI Activist on Breaking Down Barriers to Health Despite Deadly Conflict
I had imagined this year’s International Day Against Homophobia, Transphobia and Biphobia very differently. In a normal year, Ukraine’s LGBTI (lesbian, gay, bisexual, transgender and intersex) community uses this day to make our voices heard, educate... -
24 March 2022
The Pivotal Role the Private Sector Can Play in Fight Against TB
The fight against TB has been a long and arduous one. In the 20 years that the Global Fund has been operating, the TB burden has been declining steadily, but the threat of multidrug-resistant TB looms large, and in 2020, the arrival of COVID-19 set u... -
31 January 2022
Fighting AIDS and COVID-19 Depend on a Firm Foundation
Twenty years ago, the world faced a devastating pandemic that was spreading rapidly around the world. Then, 5 million people were being infected with HIV and 3 million were dying from AIDS each year. -
13 January 2022
Data Agility: A Fashionable Term, or a Game Changer for Global Health?
In the past two years, the COVID-19 pandemic and responses to it have caused a massive disruption of essential health services, especially those supporting prevention, diagnosis and treatment of HIV, tuberculosis (TB) and malaria. Despite global effo... -
01 December 2021
The Next Chapter of Our Fight Against HIV
Pandemics exacerbate and thrive on inequity. They find the fissures in our societies and deepen them. As a result, the poorest and most marginalized always suffer the most. -
22 November 2021
“We must invest in our healers”: Dr. Zolelwa Sifumba is Fighting for Health Workers on the Front Line
Dr. Zolelwa Sifumba is a health worker, multidrug-resistant tuberculosis (MDR-TB) survivor, Global Fund advocate and global health activist in South Africa, and Community Representative in the Access to COVID-19 Tools (ACT-) Accelerator. -
14 October 2021
Drug-resistant TB: Business As Usual No Longer An Option
I have spent the last 25 years working to prevent tuberculosis and treat people with the disease. I have seen firsthand the devastating consequences, including from drug resistant TB, which is more deadly and more difficult and expensive to treat. -
04 October 2021
Unloved, But a Life-saver – We Must Value PPE
No item has come to signal the era of COVID-19 like the face-mask. Now a common sight and a necessity for daily life, this simple yet effective device is the unsung hero of the COVID-19 response, playing a crucial role in helping protect health worke... -
17 September 2021
COVID-19 Hit HIV, TB and Malaria Programs Hard, We’re Fighting Back
The impact of COVID-19 on HIV, TB and malaria is like nothing we have seen in the 20 years we have been fighting these diseases. While our journey over the two decades has had its fair share of challenges, we always pushed forward. Until now. -
14 September 2021
Vaccines Alone Won’t Defeat the Variants
Delta is surging through both vaccinated and unvaccinated populations – increasing the risk of new mutations, and subjecting many to Long Covid. The solution must include protection, tests and treatments.